CHAR Technologies Ltd. (TSXV:YES)

Blueprint Medicines Revenue

CHAR Technologies had revenue of 726.97K CAD in the quarter ending March 31, 2025, with 2.57% growth. This brings the company's revenue in the last twelve months to 3.35M, up 63.96% year-over-year. In the fiscal year ending September 30, 2024, CHAR Technologies had annual revenue of 3.16M with 58.07% growth.

• Revenue (ttm): 3.35M
• Revenue Growth: +63.96%
• P/S Ratio: 8.66
• Revenue / Employee: 3.35M
• Employees: 1
• Market Cap: 29.02M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	3.16M	1.16M	58.07%
Sep 30, 2023	2.00M	540.88K	37.06%
Sep 30, 2022	1.46M	81.44K	5.91%
Sep 30, 2021	1.38M	-381.90K	-21.70%
Sep 30, 2020	1.76M	137.24K	8.46%